Cancer Vaccine Week articles from July 2008

Cancer Vaccine Week archives from July 2008

Improved culture system for hepatitis C virus infection.
July 28, 2008... A University of California, San Diego School of Medicine researcher has developed the first tissue culture of normal, human liver cells that can model infection with the Hepatitis C virus (HCV) and provide a realistic environment to evaluate...

New cancer vaccines data have been reported by A. Wondimu and co-authors.
July 28, 2008... " Because of its restricted distribution in normal tissues and its high expression on tumors of neuroectodermal origin, GD2 ganglioside is an excellent target for active specific immunotherapy. However, GD2 usually elicits low-titered IgM and...

New findings from C. Gravekamp and co-researchers in the area of cancer vaccines described.
July 28, 2008... "Metastatic breast cancer is an important contributor to morbidity and mortality. Hence, new therapies are needed that target breast cancer metastases," investigators in the United States report (see also Cancer Vaccines). "Here, we focus...

Research from Fudan University in the area of cancer vaccines published.
July 28, 2008... "Induction of anti-tumor immune responses by dendritic cells (DCs) transduced with a recombinant adeno-associated virus type 2 (rAAV2) encoding tumor antigens is considered a promising approach for cancer vaccine development. CML28, a novel...

Research results from R. Harrop and co-authors update knowledge of cancer vaccines.
July 28, 2008... "Modified vaccinia Ankara (MVA) encoding the tumor antigen 5T4 (TroVax((R))) has been evaluated in an open label phase II study in metastatic colorectal cancer patients. The primary objective was to assess the safety and immunogenicity of...

Research conducted at P. Hersey and co-authors has provided new information about melanoma.
July 28, 2008... According to a study from Newcastle, Australia, " In the present study, we have examined whether treatment of patients with metastatic melanoma with matured dendritic cell (DC) vaccines with or without low dose IL-2 may improve treatment...

Research on cancer vaccines described by scientists at National Institutes of Health.(Report)
July 28, 2008... New research, 'Vaccination with a recombinant saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses,' is the subject of a report. "Saccharomyces cerevisiae, a nonpathogenic...

Research on cancer vaccines published by scientists at University Hospital, Second Department of Internal Medicine.
July 28, 2008... Fresh data on cancer are presented in the report 'Vaccine strategies in the treatment of low-grade non-Hodgkin lymphoma.' According to a study from Athens, Greece, "Recent years have witnessed the development of a variety of promising...

Scientists at University of Massachusetts report research in cancer vaccines.
July 28, 2008... A new study, 'Concerted potent humoral immune responses to autoantigens are associated with tumor destruction and favorable clinical outcomes without autoimmunity,' is now available. "The therapeutic importance of immune responses against...

Findings from Y. Sun et al in cancer vaccines therapy reported.(Report)
July 28, 2008... Investigators publish new data in the report 'Human CD4+ T lymphocytes recognize a vascular endothelial growth factor receptor-2-derived epitope in association with HLA-DR.' According to recent research from Langen, Germany, "Given the multiple...

Researchers from Hebrew University publish findings in immunization.
July 28, 2008... Scientists discuss in 'DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis' new findings in immunization. According to recent research from Jerusalem, Israel, "We have shown recently that cDNA...

Advaxis, Inc Initiation Coverage Review Issued By Scimitar Equity, LLC.
July 28, 2008... Scimitar Equity, LLC issues a review of Advaxis, Inc (BULLETIN BOARD: ADXS) , entitled, "The New Generation of Cancer Immunotherapeutics" (see also Cancer Vaccines). This review is available at website: www.scimitarequity.com. Based in...

In Spite of Setbacks, Therapeutic Cancer Vaccines Continue to Make Gains.
July 28, 2008... Efforts to up-regulate the human immune system to recognize and destroy tumor cells with minimal side effects and collateral damage to healthy tissue continue to attract a mixture of optimism and determination from vaccine developers and...

Northwest Biotherapeutics to Present at Next Generation Vaccine Conference.(Conference news)
July 28, 2008... Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC Bulletin Board: NWBO), (the "Company or NWBT"), announced that Dr. Alton L. Boynton, its President and Chief Executive Officer, will deliver a presentation updating the Company's progress...